Members of the Gladstone community raised funds and participated in the 2015 Annual Walk to End Alzheimer's.
The Gladstone community raised funds and joined thousands of supporters at the 2015 Bay Area Heart Walk.
The Gladstone Institutes is pleased to present the inaugural Ogawa-Yamanaka Stem Cell Prize to Masayo Takahashi, MD, PhD.
For nearly 25 years, Science for Admin has given Gladstone administrators the opportunity to learn first-hand about the science they support. The very first talk in the Science for Admin series was given on September 18, 1991, by now-retired investigator Dr. Karl Weisgraber.
Diversity Interns celebrated their research accomplishments after completing summer internships in labs at Gladstone.
Victoria Rafalski, a postdoctoral scholar in the Akassoglou lab, encourages young scientists to pursue a career that aligns with their personal values.
By training scientists in Africa, Stefanie Sowinski is empowering local researchers to better fight infectious diseases and improving health on a global level.
The Gladstone Histology and Light Microscopy Core welcomes new staff to revitalize its state-of-the-art services for preparing histological samples and visualizing them with microscopy
Gladstone encourages its community to team up and showcase the many benefits of cycling by biking to work on Bike to Work Day.
Kainat Shaikh received a highly competitive Ron Mardigian Scholarship from Bio-Rad after working to Dr. JJ Miranda as a Gladstone Summer Scholar.
Advanced imaging and computational technology facilitate the search for cures.
Using his unique chemical cocktail, Gladstone’s Sheng Ding has regenerated the cells that die in paralyzing spinal cord injuries.
After studying HIV for more than 30 years, I didn’t expect to be surprised. However, recent research at the Gladstone Institutes has radically changed our fundamental understanding of how HIV works.
Jeanne Paz can stop seizures using light. Her groundbreaking work may transform epilepsy research and lead to better treatments.
Discovering the earliest signs of heart development brings us one step closer to our ultimate goal: creating a complete blueprint for building new hearts.
At the Spring 2015 Gladstone President's Council Symposium, Disrupting Aging, experts across all three institutes described how aging relates to their research.
The initiative will fast-track new approaches to treat Alzheimer’s disease.
The new system could serve as a drug-screening tool to make pregnancies safer.
The discovery of cell reprogramming by Shinya Yamanaka changed the way scientists see cell biology, but the details of how it works are still being defined. In a recent paper, the labs of Yamanaka and Bruce Conklin show how one key factor—NANOG—is involved in the process.
Collaborations have been key to Gladstone’s scientific success since its founding, and its community believes that the biggest challenges in science are better met by bringing together researchers with diverse backgrounds.
Dr. Warner Greene urged graduates to be present, be prepared to reinvent themselves, be a bridge builder, be willing to pay it forward, and be committed to excellence.
With the opening of the Thermo Fisher Scientific Proteomics Facility for Disease Target Discovery, the Gladstone Institutes has taken a major step forward in accelerating protein research.
Brianna Bibel, an undergraduate student at St. Mary’s College of California, has joined the lab of Dr. Steve Finkbeiner for the summer after receiving a 2015 Donald A. King Summer Research Fellowship from the Huntington’s Disease Society of America (HDSA).
Revelations about a key cellular pathway have important implications for neurodegenerative diseases like ALS and frontotemporal dementia.
The new strategy is more sustainable and less risky than the current standard therapies.